Clare Ozawa is Director of Oyster Point Pharma, Inc.. Currently has a direct ownership of 0 shares of OYST, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 14,637 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Clare Ozawa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
SELL
Sale (or disposition) back to the issuer
-
14,637 Reduced 100.0%
0 Common Stock
Jun 06 2022
BUY
Grant, award, or other acquisition
-
3,573 Added 19.62%
14,637 Common Stock
Jan 05 2022
BUY
Other acquisition or disposition
-
120 Added 1.07%
11,064 Common Stock
Dec 21 2021
BUY
Other acquisition or disposition
-
120 Added 1.08%
10,944 Common Stock
Jun 07 2021
BUY
Grant, award, or other acquisition
-
3,466 Added 24.25%
10,824 Common Stock
May 12 2021
BUY
Other acquisition or disposition
-
193 Added 2.56%
7,358 Common Stock
Mar 26 2021
BUY
Other acquisition or disposition
-
193 Added 2.62%
7,165 Common Stock
Feb 17 2021
BUY
Other acquisition or disposition
-
372 Added 5.07%
6,972 Common Stock
CO

Clare Ozawa

Director
Princeton, NJ

Track Institutional and Insider Activities on OYST

Follow Oyster Point Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OYST shares.

Notify only if

Insider Trading

Get notified when an Oyster Point Pharma, Inc. insider buys or sells OYST shares.

Notify only if

News

Receive news related to Oyster Point Pharma, Inc.

Track Activities on OYST